| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $502.3M | +20.7% | +10.5% |
| Cost of Revenue | $139.1M | +3.8% | +7.1% |
| Gross Profit | $363.2M | +28.7% | +11.9% |
| R&D Expense | $52.5M | -9.0% | +2.2% |
| SG&A Expense | $58.0M | +3.6% | +6.4% |
| Operating Income | $157.0M | +123.0% | +23.6% |
| Pre-tax Income | $157.0M | +123.8% | +24.1% |
| Income Tax | $45.8M | +129.2% | +30.5% |
| Net Income | $111.3M | +121.6% | +21.6% |
| EPS (Basic) | $2.07 | +122.6% | +26.2% |
| EPS (Diluted) | $2.05 | +122.8% | +27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $299.7M | +84.5% | -37.3% |
| Accounts Receivable | $48.4M | +9.9% | +10.9% |
| Current Assets | $4.36B | -26.1% | +6.2% |
| Total Assets | $5.44B | -21.9% | +5.3% |
| Current Liabilities | $4.04B | -28.9% | +11.4% |
| Long-term Debt | $81.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $421.4M | — | — |
| Capital Expenditures | $15.5M | — | — |
| Investing Cash Flow | -$53.7M | — | — |
| Financing Cash Flow | $680.5M | — | — |
| Free Cash Flow | $405.8M | — | — |
| -66.7% |
| Total Liabilities | $4.26B | -27.4% | +7.7% |
| Stockholders' Equity | $1.18B | +7.5% | -2.3% |